People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Radionetics Oncology, Inc. | — | Pharmaceuticals | Series C | $54.2M | $652.4M | 2023 |
Yunfei Zhu at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Yunfei Zhu on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Schwab | 1 | 16 |
| Dan Estes | 1 | 3 |
| Brett Ewald | 1 | 1 |
| Umesh Gangadharmath | 1 | 1 |
| Istvan Molnar | 1 | 1 |
| Ana Kusnetzow | 1 | 1 |
| Scott Struthers | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.